{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:02:43Z","timestamp":1793246563310,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovative and Entrepreneurship Training Program for college students","award":["S202310752019"],"award-info":[{"award-number":["S202310752019"]}]},{"name":"Innovative and Entrepreneurship Training Program for college students","award":["S202310752018"],"award-info":[{"award-number":["S202310752018"]}]},{"name":"Ningxia Science and Technology Benefiting People Program","award":["No.2022CMG03064"],"award-info":[{"award-number":["No.2022CMG03064"]}]},{"name":"Ningxia Key Research and Development Program","award":["No.2023BEG02015"],"award-info":[{"award-number":["No.2023BEG02015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05111-6","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:31:05Z","timestamp":1762162265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the effect of Huangqi Fuling Decoction on gastric cancer based on UPLC-MS, network pharmacology and experiments in vitro"],"prefix":"10.1186","volume":"25","author":[{"given":"Doudou","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fandi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"3","key":"5111_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"5111_CR2","doi-asserted-by":"publisher","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167\u201392. https:\/\/doi.org\/10.6004\/jnccn.2022.0008.","DOI":"10.6004\/jnccn.2022.0008"},{"issue":"14","key":"5111_CR3","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.22.01997","volume":"41","author":"L Sandhya","year":"2023","unstructured":"Sandhya L, Devi Sreenivasan N, Goenka L, Dubashi B, Kayal S, Solaiappan M, et al. Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer. J Clin Oncol. 2023;41(14):2617\u201327. https:\/\/doi.org\/10.1200\/JCO.22.01997.","journal-title":"J Clin Oncol"},{"key":"5111_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102751","volume":"127","author":"L Rached","year":"2024","unstructured":"Rached L, Laparra A, Sakkal M, Danlos FX, Barlesi F, Carbonnel F, et al. Toxicity of immunotherapy combinations with chemotherapy across tumor indications: current knowledge and practical recommendations. Cancer Treat Rev. 2024;127:102751. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102751.","journal-title":"Cancer Treat Rev"},{"issue":"04","key":"5111_CR5","first-page":"554","volume":"44","author":"D Mengyu","year":"2024","unstructured":"Mengyu D, Fei S, Gao J. Huangqi Guizhi Wuwu Decoction for treating peripheral nerve toxicity after chemotherapy. Jilin traditional Chinese medicine. 2024;44(04):554\u20138.","journal-title":"Jilin traditional Chinese medicine"},{"issue":"12","key":"5111_CR6","first-page":"958","volume":"47","author":"Y Zhizhen","year":"2022","unstructured":"Zhizhen Y, Shuchao X, Li J. The effect of Huangqi Guizhi Wuwu decoction combined with Neixiao pill for external application in the treatment of upper limb lymphedema after breast cancer surgery. Cancer Prev Treat Res. 2022;47(12):958\u201362.","journal-title":"Cancer Prev Treat Res"},{"issue":"10","key":"5111_CR7","first-page":"50","volume":"51","author":"L Zhidan","year":"2019","unstructured":"Zhidan L, Kanger D. Analysis on the treatment of hand and foot syndrome with Huangqi Guizhi Wuwu Decoction. New Trad Chin Med. 2019;51(10):50\u20131.","journal-title":"New Trad Chin Med"},{"key":"5111_CR8","unstructured":"Mingzhu L. Study on the mechanism of Huangqi Guizhi Wuwu Decoction in preventing and treating neuropathic pain induced by oxaliplatin, 2022."},{"issue":"7","key":"5111_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/ptr.6057","volume":"32","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wen K. Astragaloside IV inhibits TGF-\u03b21-induced epithelial-mesenchymal transition through inhibition of the PI3K\/Akt\/NF-\u03baB pathway in gastric cancer cells. Phytother Res. 2018;32(7):1289\u201396. https:\/\/doi.org\/10.1002\/ptr.6057.","journal-title":"Phytother Res"},{"issue":"7","key":"5111_CR10","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/ptr.6070","volume":"32","author":"C Zhang","year":"2018","unstructured":"Zhang C, Cai T, Zeng X, et al. Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: regulation on glycolysis through miRNA-34a\/LDHA pathway. Phytother Res. 2018;32(7):1364\u201372.","journal-title":"Phytother Res"},{"issue":"4","key":"5111_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1142\/S0192415X18500465","volume":"46","author":"C Lu","year":"2018","unstructured":"Lu C, Cai D, Ma J. Pachymic acid sensitizes gastric cancer cells to radiation therapy by upregulating Bax through hypoxia. Am J Chin Med. 2018;46(4):875\u201390.","journal-title":"Am J Chin Med"},{"key":"5111_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154902","volume":"116","author":"M Chen","year":"2023","unstructured":"Chen M, Zhang R, Chen Y, et al. Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress. Phytomedicine. 2023;116:154902.","journal-title":"Phytomedicine"},{"issue":"11","key":"5111_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u201390.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"5111_CR14","first-page":"1","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang X, Wang ZY, Zheng JH, Li S. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021;19(1):1\u201311.","journal-title":"Chin J Nat Med"},{"key":"5111_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"issue":"D1","key":"5111_CR16","doi-asserted-by":"publisher","first-page":"D1117","DOI":"10.1093\/nar\/gkx1028","volume":"46","author":"L Huang","year":"2018","unstructured":"Huang L, Xie D, Yu Y, et al. TCMID 2.0: a comprehensive resource for TCM. Nucleic Acids Res. 2018;46(D1):D1117\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"5111_CR17","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.apsb.2023.03.012","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li X, Shi Y, et al. ETCM v2.0: an update with comprehensive resource and rich annotations for traditional Chinese medicine. Acta Pharm Sin B. 2023;13(6):2559\u201371.","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"5111_CR18","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20220874","volume":"120","author":"R Xu","year":"2023","unstructured":"Xu R, Ma LL, Cui S, Chen L, Xu H. Bioinformatics and systems biology approach to identify the pathogenetic link between heart failure and sarcopenia. Arq Bras Cardiol. 2023;120(10):e20220874.","journal-title":"Arq Bras Cardiol"},{"issue":"W1","key":"5111_CR19","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5111_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/pro.3711","volume":"29","author":"M Kanehisa","year":"2020","unstructured":"Kanehisa M, Sato Y. Kegg mapper for inferring cellular functions from protein sequences. Protein Sci. 2020;29(1):28\u201335.","journal-title":"Protein Sci"},{"issue":"W1","key":"5111_CR21","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"5111_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","author":"CJ Liu","year":"2023","unstructured":"Liu CJ, Hu FF, Xie GY, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbac558.","journal-title":"Brief Bioinform"},{"issue":"3","key":"5111_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"JT Rich","year":"2010","unstructured":"Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010;143(3):331\u20136.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"D1","key":"5111_CR24","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49(D1):D1388\u201395.","journal-title":"Nucleic Acids Res"},{"key":"5111_CR25","unstructured":"UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023; 51(D1): D523-D531."},{"issue":"8","key":"5111_CR26","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021;61(8):3891\u20138.","journal-title":"J Chem Inf Model"},{"issue":"12","key":"5111_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083922","volume":"8","author":"KY Hsin","year":"2013","unstructured":"Hsin KY, Ghosh S, Kitano H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS One. 2013;8(12):e83922.","journal-title":"PLoS One"},{"issue":"47","key":"5111_CR28","doi-asserted-by":"publisher","first-page":"19090","DOI":"10.1073\/pnas.1116998108","volume":"108","author":"N Slavov","year":"2011","unstructured":"Slavov N, Macinskas J, Caudy A, Botstein D. Metabolic cycling without cell division cycling in respiring yeast. Proc Natl Acad Sci U S A. 2011;108(47):19090\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"5111_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tem.2022.04.006","volume":"33","author":"P Icard","year":"2022","unstructured":"Icard P, Simula L. Metabolic oscillations during cell-cycle progression. Trends Endocrinol Metab. 2022;33(7):447\u201350.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"5111_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41419-018-0930-1","volume":"9","author":"TW Kim","year":"2018","unstructured":"Kim TW, Lee SY, Kim M, Cheon C, Ko SG. Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells. Cell Death Dis. 2018;9(9):875. https:\/\/doi.org\/10.1038\/s41419-018-0930-1.","journal-title":"Cell Death Dis"},{"key":"5111_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155090","volume":"121","author":"R Wang","year":"2023","unstructured":"Wang R, Deng Z, Zhu Z, Wang J, Yang X, Xu M, et al. Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway. Phytomedicine. 2023;121:155090. https:\/\/doi.org\/10.1016\/j.phymed.2023.155090.","journal-title":"Phytomedicine"},{"issue":"8","key":"5111_CR32","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1002\/ptr.7838","volume":"37","author":"J Cao","year":"2023","unstructured":"Cao J, Ma X, Yan X, Zhang G, Hong S, Ma R, et al. Kaempferol induces mitochondrial dysfunction and mitophagy by activating the LKB1\/AMPK\/MFF pathway in breast precancerous lesions. Phytother Res. 2023;37(8):3602\u201316. https:\/\/doi.org\/10.1002\/ptr.7838.","journal-title":"Phytother Res"},{"key":"5111_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914519","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Fang G, Pang Y, Wang X. Combination of Kaempferol and Docetaxel induces autophagy in prostate cancer cells in vitro and in vivo. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914519.","journal-title":"Int J Mol Sci"},{"key":"5111_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2024.01.002","volume":"213","author":"L Ding","year":"2024","unstructured":"Ding L, Dang S, Sun M, Zhou D, Sun Y, Li E, et al. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2\/p-DRP1 and NRF2\/GPX4 axes. Free Radic Biol Med. 2024;213:150\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.01.002.","journal-title":"Free Radic Biol Med"},{"key":"5111_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091477","author":"CM Liu","year":"2017","unstructured":"Liu CM, Kao CL, Tseng YT, Lo YC, Chen CY. Ginger phytochemicals inhibit cell growth and modulate drug resistance factors in docetaxel resistant prostate cancer cell. Molecules. 2017. https:\/\/doi.org\/10.3390\/molecules22091477.","journal-title":"Molecules"},{"issue":"5","key":"5111_CR36","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/ptr.6325","volume":"33","author":"Y Luo","year":"2019","unstructured":"Luo Y, Zha L, Luo L, Chen X, Zhang Q, Gao C, et al. [6]-gingerol enhances the cisplatin sensitivity of gastric cancer cells through inhibition of proliferation and invasion via PI3K\/AKT signaling pathway. Phytother Res. 2019;33(5):1353\u201362. https:\/\/doi.org\/10.1002\/ptr.6325.","journal-title":"Phytother Res"},{"key":"5111_CR37","doi-asserted-by":"publisher","first-page":"1056687","DOI":"10.3389\/fphar.2022.1056687","volume":"13","author":"N Qu","year":"2022","unstructured":"Qu N, Qu J, Huang N, Zhang K, Ye T, Shi J, et al. Calycosin induces autophagy and apoptosis via Sestrin2\/AMPK\/mTOR in human papillary thyroid cancer cells. Front Pharmacol. 2022;13:1056687. https:\/\/doi.org\/10.3389\/fphar.2022.1056687.","journal-title":"Front Pharmacol"},{"key":"5111_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154924","volume":"118","author":"Y Li","year":"2023","unstructured":"Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, et al. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-\u03b1 splice variant ER-\u03b130-mediated PI3K\/AKT signaling pathway. Phytomedicine. 2023;118:154924. https:\/\/doi.org\/10.1016\/j.phymed.2023.154924.","journal-title":"Phytomedicine"},{"issue":"1","key":"5111_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18037","volume":"28","author":"G Wu","year":"2024","unstructured":"Wu G, Qi G, Liu Y, Gan J, Xie C, Wu Q, et al. ER-\u03b136 is involved in calycosin inhibition of IL-6 production in macrophages. J Cell Mol Med. 2024;28(1):e18037. https:\/\/doi.org\/10.1111\/jcmm.18037.","journal-title":"J Cell Mol Med"},{"key":"5111_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TB Emran","year":"2022","unstructured":"Emran TB, Shahriar A, Mahmud AR, Rahman T, Abir MH, Siddiquee MF, et al. Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front Oncol. 2022;12:891652. https:\/\/doi.org\/10.3389\/fonc.2022.891652.","journal-title":"Front Oncol"},{"issue":"9","key":"5111_CR41","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","volume":"19","author":"C Gravalos","year":"2008","unstructured":"Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19(9):1523\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdn169.","journal-title":"Ann Oncol"},{"issue":"9742","key":"5111_CR42","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(10)61121-X.","journal-title":"Lancet"},{"issue":"11","key":"5111_CR43","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1158\/1078-0432.CCR-21-4011","volume":"28","author":"V Cheng","year":"2022","unstructured":"Cheng V, de Pennington N, Zakaria R, Larkin JR, Serres S, Sarkar M, et al. VCAM-1-targeted MRI Improves Detection of the Tumor-brain Interface. Clin Cancer Res. 2022;28(11):2385\u201396. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-4011.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5111_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/neuonc\/noz169","volume":"22","author":"A Corroyer-Dulmont","year":"2020","unstructured":"Corroyer-Dulmont A, Valable S, Falzone N, Frelin-Labalme AM, Tietz O, Toutain J, et al. VCAM-1 targeted alpha-particle therapy for early brain metastases. Neuro Oncol. 2020;22(3):357\u201368. https:\/\/doi.org\/10.1093\/neuonc\/noz169.","journal-title":"Neuro Oncol"},{"issue":"1","key":"5111_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00447-z","volume":"7","author":"B Zhu","year":"2023","unstructured":"Zhu B, Wang X, Shimura T, Huang AC, Kong N, Dai Y, et al. Development of potent antibody drug conjugates against ICAM1(+) cancer cells in preclinical models of cholangiocarcinoma. NPJ Precis Oncol. 2023;7(1):93. https:\/\/doi.org\/10.1038\/s41698-023-00447-z.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"5111_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT. Mapk signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12(1):9\u201318. https:\/\/doi.org\/10.1038\/sj.cr.7290105.","journal-title":"Cell Res"},{"issue":"3","key":"5111_CR47","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454.","journal-title":"Exp Ther Med"},{"issue":"10","key":"5111_CR48","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332. https:\/\/doi.org\/10.1038\/s41580-020-0255-7.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"5111_CR49","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/1873-3468.12740","volume":"591","author":"EB \u00dcnal","year":"2017","unstructured":"\u00dcnal EB, Uhlitz F, Bl\u00fcthgen N. A compendium of ERK targets. FEBS Lett. 2017;591(17):2607\u201315. https:\/\/doi.org\/10.1002\/1873-3468.12740.","journal-title":"FEBS Lett"},{"issue":"2","key":"5111_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncb1676","volume":"10","author":"JY Yang","year":"2008","unstructured":"Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol. 2008;10(2):138\u201348. https:\/\/doi.org\/10.1038\/ncb1676.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"5111_CR51","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/sj.emboj.7601723","volume":"26","author":"KE Ewings","year":"2007","unstructured":"Ewings KE, Hadfield-Moorhouse K, Wiggins CM, Wickenden JA, Balmanno K, Gilley R, et al. ERK1\/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J. 2007;26(12):2856\u201367. https:\/\/doi.org\/10.1038\/sj.emboj.7601723.","journal-title":"EMBO J"},{"issue":"9","key":"5111_CR52","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/cdd.2012.21","volume":"19","author":"J Lopez","year":"2012","unstructured":"Lopez J, Hesling C, Prudent J, Popgeorgiev N, Gadet R, Mikaelian I, et al. Src tyrosine kinase inhibits apoptosis through the Erk1\/2- dependent degradation of the death accelerator Bik. Cell Death Differ. 2012;19(9):1459\u201369. https:\/\/doi.org\/10.1038\/cdd.2012.21.","journal-title":"Cell Death Differ"},{"issue":"6","key":"5111_CR53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.molcel.2011.02.031","volume":"41","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G, et al. ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol Cell. 2011;41(6):661\u201371. https:\/\/doi.org\/10.1016\/j.molcel.2011.02.031.","journal-title":"Mol Cell"},{"issue":"7","key":"5111_CR54","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1128\/MCB.24.7.3025-3035.2004","volume":"24","author":"MS Woo","year":"2004","unstructured":"Woo MS, Ohta Y, Rabinovitz I, Stossel TP, Blenis J. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol Cell Biol. 2004;24(7):3025\u201335. https:\/\/doi.org\/10.1128\/MCB.24.7.3025-3035.2004.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"5111_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.molcel.2004.10.006","volume":"16","author":"S Ishibe","year":"2004","unstructured":"Ishibe S, Joly D, Liu ZX, Cantley LG. Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol Cell. 2004;16(2):257\u201367. https:\/\/doi.org\/10.1016\/j.molcel.2004.10.006.","journal-title":"Mol Cell"},{"issue":"7","key":"5111_CR56","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/molecules27072165","volume":"27","author":"MR Islam","year":"2022","unstructured":"Islam MR, Islam F, Nafady MH, Akter M, Mitra S, Das R, et al. Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint. Molecules. 2022;27(7):2165. https:\/\/doi.org\/10.3390\/molecules27072165.","journal-title":"Molecules"},{"issue":"23","key":"5111_CR57","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.3390\/molecules26237368","volume":"26","author":"A Rauf","year":"2021","unstructured":"Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules. 2021;26(23):7368. https:\/\/doi.org\/10.3390\/molecules26237368.","journal-title":"Molecules"},{"issue":"1","key":"5111_CR58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12906-023-03985-y","volume":"23","author":"J Cai","year":"2023","unstructured":"Cai J, Chen Y, Wang K, Li Y, Wu J, Yu H, et al. Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer. BMC Complement Med Ther. 2023;23(1):158. https:\/\/doi.org\/10.1186\/s12906-023-03985-y.","journal-title":"BMC Complement Med Ther"},{"key":"5111_CR59","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.csbj.2020.05.004","volume":"18","author":"Y Dai","year":"2020","unstructured":"Dai Y, Qiang W, Yu X, Cai S, Lin K, Xie L, et al. Guizhi fuling decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS(2) technology and systems pharmacology. Comput Struct Biotechnol J. 2020;18:1121\u201336. https:\/\/doi.org\/10.1016\/j.csbj.2020.05.004.","journal-title":"Comput Struct Biotechnol J"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05111-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:31:08Z","timestamp":1762162268000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05111-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5111"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05111-6","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics committee approval was needed for publicly available anonymous expression and clinical information data sets.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}